Q3 Results Highlights February 14, 2025: Manappuram Finance reported a consolidated net profit of ₹278.46 crore for the December 2024 quarter, significantly down from ₹575.31 crore in the same ...

The pharmaceutical industry has a crucial role in modern healthcare, but it also has a significant environmental footprint. From large-scale solvent use and carbon emissions to water pollution and ...

Shares of Ascendis Pharma (ASND) are down $5.82, or 4%, to $155.33 in morning trading in New York. The move lower began near the open and may be related to the start of today’s Committee for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Royalty Pharma (RPRX) announced the appointment of Vlad Coric to the company’s board of directors, effective immediately. Vlad Coric is the chairman and CEO of Biohaven (BHVN). Published first ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Pharma stocks crashed 6 per cent before closing 4 per cent lower on Friday after US President Donald Trump reportedly threatened tariffs on pharma products at “levels never seen before.” ...

Iris Bincovich Innocan Pharma's CEO stated: "It is an honour to receive the continued support of our investors, who have placed their trust in Innocan's proprietary technology". The Company ...

Zynext Ventures USA LLC today announced its investment in Feldan Therapeutics (Feldan), a Canada-based early clinical-stage ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven supply ...

Roni Kamhi, CEO BI Sky Global and COO of Innocan Pharma commented: "We are very pleased with our outstanding results and especially our strong revenue growth. At BI Sky Global we are clearly ...